GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » EV-to-EBIT
中文

Cannabis Strategic Ventures (Cannabis Strategic Ventures) EV-to-EBIT

: 0.00 (As of Today)
View and export this data going back to 2005. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cannabis Strategic Ventures's Enterprise Value is $0.00 Mil. Cannabis Strategic Ventures's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-10.44 Mil. Therefore, Cannabis Strategic Ventures's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Cannabis Strategic Ventures's EV-to-EBIT or its related term are showing as below:

NUGS's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.185
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cannabis Strategic Ventures's Enterprise Value for the quarter that ended in Jun. 2020 was $42.92 Mil. Cannabis Strategic Ventures's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-10.44 Mil. Cannabis Strategic Ventures's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 was -24.32%.


Cannabis Strategic Ventures EV-to-EBIT Historical Data

The historical data trend for Cannabis Strategic Ventures's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
EV-to-EBIT
Get a 7-Day Free Trial -18.03 16.49 -70.01 -9.37 -3.12

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.65 -3.18 -1.11 -3.12 -4.11

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Strategic Ventures EV-to-EBIT Distribution

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's EV-to-EBIT falls into.



Cannabis Strategic Ventures EV-to-EBIT Calculation

Cannabis Strategic Ventures's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-10.436
=0.00

Cannabis Strategic Ventures's current Enterprise Value is $0.00 Mil.
Cannabis Strategic Ventures's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Strategic Ventures  (OTCPK:NUGS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cannabis Strategic Ventures's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2020 ) =EBIT / Enterprise Value (Q: Jun. 2020 )
=-10.436/42.9170921
=-24.32 %

Cannabis Strategic Ventures's Enterprise Value for the quarter that ended in Jun. 2020 was $42.92 Mil.
Cannabis Strategic Ventures's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Strategic Ventures EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Traded in Other Exchanges
N/A
Address
9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Executives
Gordon Samson director, officer: Chief Financial Officer 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown director, officer: VP, Corporate Development 9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster director, officer: CFO, Secretary & Treasurer 5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler director, 10 percent owner, officer: President #604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman director, 10 percent owner, officer: SECRETARY/TREASURER 5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall director, 10 percent owner, officer: President 2435 WEST 7TH AVENUE VANCOUVER A1 00000